| Financial Year |
March 31 2023 |
| Monetary Funds |
7,622,946,286.32 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,726,733,576.74 |
| Accounts Receivable |
1,203,519,429.55 |
| Advances to Suppliers |
121,252,410.07 |
| Other Receivables |
4,231,732.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,297,720,989.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
645,398,256.68 |
| Total Current Assets |
13,621,802,680.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,654,461,466.34 |
| Investment Properties |
14,227,222.36 |
| Fixed Assetes |
11,796,586,112.47 |
| Under-construction Projects |
775,596,579.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
727,160,642.25 |
| R&D expenses |
-- |
| Goodwill |
10,359,538.23 |
| Long-Term Deferred and Prepaid Expenses |
39,260,913.32 |
| Deferred Income Tax Assets |
185,102,028.59 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
15,398,089,120.31 |
| Total Assets |
29,019,891,801.29 |
| Short-Term Loans |
1,750,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
866,759,084.10 |
| Accounts Payable |
4,567,967,184.93 |
| Accounts Received In Advance |
74,262.85 |
| Employee Compensation Payable |
109,795,408.22 |
| Taxes Payable |
330,995,460.16 |
| Interest Payable |
33,984,082.16 |
| Dividend Payable |
-- |
| Other payables |
122,096,352.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,021,627,524.53 |
| Other Current Liabilities |
63,649,732.15 |
| Sub-Total of Current Liabilities |
10,393,228,207.21 |
| Long-term Loans |
761,000,000.00 |
| Bonds Payable |
698,518,823.12 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
665,870,116.62 |
| Deferred Income Tax Liabilities |
133,771,158.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,586,416,014.72 |
| Total Liabilities |
12,979,644,221.93 |
| Paid-In Capital(Or Share Stock) |
1,587,799,851.00 |
| Capital Surplus |
1,704,251,123.58 |
| Surplus Reserve |
1,955,725,130.84 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
8,832,479,185.44 |
| Minority Stockholder's Interest |
1,525,350,522.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
14,514,897,057.05 |
| Owner's Equity（Stockholder's Equity） |
16,040,247,579.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
29,019,891,801.29 |
